Cyclo Therapeutics, Inc. (CYTH) DCF Valuation

Cyclo Therapeutics, Inc. (CYTH) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Cyclo Therapeutics, Inc. (CYTH) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial prospects of Cyclo Therapeutics, Inc. (CYTH) with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and costs to calculate the intrinsic value of Cyclo Therapeutics, Inc. (CYTH) and inform your investment decisions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 1.0 .9 1.6 1.4 1.1 1.2 1.2 1.3 1.4 1.5
Revenue Growth, % 0 -10.31 75.54 -13.24 -21.76 7.56 7.56 7.56 7.56 7.56
EBITDA -7.4 -8.9 -14.3 -15.6 -20.0 -1.2 -1.2 -1.3 -1.4 -1.5
EBITDA, % -733.23 -990.58 -899.88 -1134.09 -1860.9 -100 -100 -100 -100 -100
Depreciation .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 0.56404 1.41 1.06 1.42 1.79 1.25 1.25 1.25 1.25 1.25
EBIT -7.4 -9.0 -14.3 -15.6 -20.1 -1.2 -1.2 -1.3 -1.4 -1.5
EBIT, % -733.8 -991.99 -900.94 -1135.51 -1862.69 -100 -100 -100 -100 -100
Total Cash 2.8 12.8 16.6 1.5 9.2 1.2 1.2 1.3 1.4 1.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .2 .1 .5 .1 .1
Account Receivables, % 18.12 12.37 34 4 11.37
Inventories .2 .2 .2 .3 .3 .2 .3 .3 .3 .3
Inventories, % 24.09 26.34 14.34 18.5 23.63 21.38 21.38 21.38 21.38 21.38
Accounts Payable 3.1 3.5 3.7 2.2 4.9 1.2 1.2 1.3 1.4 1.5
Accounts Payable, % 310.24 391.98 231.94 162.38 451.18 100 100 100 100 100
Capital Expenditure .0 -.1 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -0.13145 -5.88 -1.42 -1.1 -0.22482 -1.75 -1.75 -1.75 -1.75 -1.75
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -7.5 -8.9 -14.3 -15.4 -20.1 -1.2 -1.2 -1.3 -1.4 -1.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -4.8 -8.5 -14.6 -16.4 -17.5 -4.9 -1.2 -1.3 -1.4 -1.5
WACC, % 5.3 5.3 5.3 5.3 5.3 5.3 5.3 5.3 5.3 5.3
PV UFCF
SUM PV UFCF -9.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -2
Terminal Value -46
Present Terminal Value -35
Enterprise Value -45
Net Debt -8
Equity Value -36
Diluted Shares Outstanding, MM 16
Equity Value Per Share -2.22

What You Will Get

  • Comprehensive CYTH Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Evaluate various scenarios to assess Cyclo Therapeutics’ future outlook.
  • User-Friendly Interface: Designed for professionals but easy to navigate for newcomers.

Key Features

  • 🔍 Real-Life CYTH Financials: Pre-filled historical and projected data for Cyclo Therapeutics, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Cyclo Therapeutics’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Cyclo Therapeutics’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • 1. Access the Model: Download and open the Excel template featuring Cyclo Therapeutics, Inc. (CYTH) preloaded data.
  • 2. Modify Key Inputs: Adjust essential variables such as growth projections, discount rates, and capital investments.
  • 3. Instant Result Generation: The DCF model automatically computes intrinsic value and net present value (NPV).
  • 4. Explore Different Scenarios: Evaluate various forecasts to understand diverse valuation possibilities.
  • 5. Present with Assurance: Deliver expert valuation findings to enhance your decision-making process.

Why Choose This Calculator for Cyclo Therapeutics, Inc. (CYTH)?

  • Accurate Data: Up-to-date financials from Cyclo Therapeutics ensure dependable valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations remove the hassle of starting from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Simple design and clear instructions make it accessible for all users.

Who Should Use This Product?

  • Investors: Evaluate Cyclo Therapeutics’ valuation before making investment decisions.
  • CFOs and Financial Analysts: Enhance valuation methodologies and validate financial forecasts.
  • Startup Founders: Understand the valuation processes of biotech companies like Cyclo Therapeutics.
  • Consultants: Provide comprehensive valuation analyses for clients in the healthcare sector.
  • Students and Educators: Utilize current data to learn and teach valuation strategies in biotechnology.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for Cyclo Therapeutics, Inc. (CYTH).
  • Real-World Data: Cyclo Therapeutics' historical and projected financials preloaded for thorough analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Graphs and tables presenting clear, actionable results for informed decision-making.

No products were found matching.